Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04580446
What this trial is testing

HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaOropharyngeal Cancer
University of Texas Southwestern Medical Center 24
Large-scale testing (Phase 3)Looking for participantsNCT05333523
What this trial is testing

Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.

Who this might be right for
Laryngeal Squamous Cell CarcinomaHypopharynx Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Radboud University Medical Center 242
Not applicableUnknownNCT06480903
What this trial is testing

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy

Who this might be right for
Nasopharyngeal CarcinomaHead and Neck CancerNasopharyngeal Cancer+1 more
The Christie NHS Foundation Trust 10
Large-scale testing (Phase 3)Looking for participantsNCT06675214
What this trial is testing

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Who this might be right for
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University 586
Testing effectiveness (Phase 2)UnknownNCT03047525
What this trial is testing

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Who this might be right for
Colorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more
Xiaoyi Huang 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07385079
What this trial is testing

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 412
Large-scale testing (Phase 3)UnknownNCT03529279
What this trial is testing

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 1,324
Early research (Phase 1)UnknownNCT01462903
What this trial is testing

Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Nasopharyngeal CarcinomaHepatocellular CarcinomaBreast Carcinoma
Sun Yat-sen University 20
Early research (Phase 1)UnknownNCT05299203
What this trial is testing

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 18
Large-scale testing (Phase 3)UnknownNCT03015727
What this trial is testing

Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 440
Not applicableStudy completedNCT03598218
What this trial is testing

Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 30
Large-scale testing (Phase 3)Study completedNCT02973386
What this trial is testing

Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients

Who this might be right for
Local Advanced High Risk Nasopharyngeal Carcinoma
Sun Yat-sen University 294
Testing effectiveness (Phase 2)UnknownNCT00634595
What this trial is testing

Trial of E10A in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous CarcinomaNasopharyngeal Carcinoma
Sun Yat-sen University 116
Testing effectiveness (Phase 2)Ended earlyNCT02225496
What this trial is testing

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Cancer
M.D. Anderson Cancer Center 1
Not applicableActive Not RecruitingNCT07088861
What this trial is testing

Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Lirong Wu 1,401
Testing effectiveness (Phase 2)Ended earlyNCT02698111
What this trial is testing

Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 20
Large-scale testing (Phase 3)Study completedNCT01434394
What this trial is testing

Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Who this might be right for
Locally Advanced Malignant NeoplasmOral CancerOropharyngeal Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 243
Testing effectiveness (Phase 2)UnknownNCT02760667
What this trial is testing

Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
George Washington University 20
Testing effectiveness (Phase 2)UnknownNCT03129412
What this trial is testing

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

Who this might be right for
Nasopharyngeal CancerNeoplasm Metastasis
Zhejiang Cancer Hospital 64
Large-scale testing (Phase 3)Active Not RecruitingNCT06295731
What this trial is testing

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc 410
Next Page